{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T05:19:12Z","timestamp":1697519952686},"reference-count":21,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T00:00:00Z","timestamp":1311897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:styled-content>Objectives<\/jats:styled-content>: To assess clinical performance of the second\u2010generation Endeavor Resolute<jats:sup>\u00ae<\/jats:sup> drug\u2010eluting stents (DES) in an unrestricted high\u2010risk cohort of patients. <jats:styled-content>Background<\/jats:styled-content>: New\u2010generation DESs aim to further increase its clinical safety and efficacy by means of more biocompatible components limiting inflammatory response, assuring strut coverage and preserving endothelial vascular function. <jats:styled-content>Methods<\/jats:styled-content>: Between January 2008 and April 2009 820 unselected consecutive high\u2010risk patients (1,352 lesions) treated with the Endeavor Resolute<jats:sup>\u00ae<\/jats:sup> stent were enrolled in an independent multicenter registry. Primary end\u2010points of this registry were immediate procedural outcome, incidence of target lesion failure (TLF, defined as composite of cardiac death, myocardial infarction, and target lesion revascularization) and rate of ARC stent thrombosis at 12\u2010months follow\u2010up. <jats:styled-content>Results<\/jats:styled-content>: High\u2010risk patient\/lesion profile included acute coronary syndrome diagnosis in 57% of patients, diabetes mellitus in 23% and ACC\/AHA type B2\/C lesion in 74%. Endeavor Resolute<jats:sup>\u00ae<\/jats:sup> stent was used in an off\u2010label indication in 52% of cases with stent\/patient ratio of 1.93 and average stented segment of 39.8\u00b126.6mm. Immediate procedural success was accomplished in 96.0% of cases and at median 12\u2010month follow\u2010up TLF rate was 7.1% with 4.0% of clinically driven repeat revascularizations and 1.1% of definite\/probable stent thrombosis incidence. At multivariable analysis, nor off\u2010label Endeavor Resolute<jats:sup>\u00ae<\/jats:sup> stent use or multiple stent implantations were associated to an increased risk of adverse events. <jats:styled-content>Conclusions<\/jats:styled-content>: Extensive use of the new Endeavor Resolute<jats:sup>\u00ae<\/jats:sup> stent was associated with favorable procedural and 12\u2010month outcomes despite the treatment of unselected complex clinical and anatomical presentation. Endeavor Resolute<jats:sup>\u00ae<\/jats:sup> stent showed excellent safety and efficacy profile also in off\u2010label indications. \u00a9 2011 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/ccd.23046","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T17:35:24Z","timestamp":1311960924000},"page":"567-574","source":"Crossref","is-referenced-by-count":7,"title":["Resolute italian study in all comers"],"prefix":"10.1002","volume":"79","author":[{"given":"Enrico","family":"Romagnoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosmo","family":"Godino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Ielasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaios","family":"Tzifos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Sciahbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Lioy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Presbitero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Sangiorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,7,29]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.854398"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.030"},{"key":"e_1_2_6_4_2","first-page":"137","article-title":"The next generation endeavor resolute stent: Role of the BioLinx polymer system","volume":"3","author":"Udipi K","year":"2007","journal-title":"EuroIntervention"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-10-0063"},{"key":"e_1_2_6_6_2","first-page":"50","article-title":"The next\u2010generation Endeavor Resolute stent: 4\u2010month clinical and angiographic results from the Endeavor Resolute first\u2010in\u2010man trial","volume":"3","author":"Meredith IT","year":"2007","journal-title":"EuroIntervention"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2009.07.007"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV5I6A114"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1004130"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.07.013"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.08.048"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.01.059"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.09.067"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.108.769042"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2009.09.014"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.11.052"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.109.886945"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.685313"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.187397"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.11.710"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.591206"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.16.1903"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.23046","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.23046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T18:16:54Z","timestamp":1697480214000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.23046"}},"subtitle":["Immediate and One\u2010Year Outcomes"],"short-title":[],"issued":{"date-parts":[[2011,7,29]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1002\/ccd.23046"],"URL":"https:\/\/doi.org\/10.1002\/ccd.23046","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,29]]}}}